Trials / Recruiting
RecruitingNCT07397403
The Efficacy of Doxycycline Post Exposure Prophylaxis for Preventing STIs Among MSM in Bangkok, Thailand.
The Efficacy of Doxycycline Post Exposure Prophylaxis for Preventing Sexually Transmitted Diseases (Gonorrhea, Chlamydia, Syphilis) Among Men Who Have Sex With Men in Bangkok, Thailand.
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- Bangrak STIs Center · Other Government
- Sex
- Male
- Age
- 18 Days – 60 Days
- Healthy volunteers
- Accepted
Summary
The objective of this research is to evaluate the efficacy and safety of doxycycline in MSM for preventing sexually transmitted infections (gonorrhea, chlamydia, and syphilis) in Thailand Participation in this study will last approximately 12 weeks and will include 2-3 clinic visits, along with 10-11 follow-up phone contacts over a period of 11 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Doxycycline (200mg/day) | Doxycycline 200 mg single dose after unprotected sex within 24-72 hours |
Timeline
- Start date
- 2025-10-06
- Primary completion
- 2026-10-05
- Completion
- 2027-05-31
- First posted
- 2026-02-09
- Last updated
- 2026-02-09
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT07397403. Inclusion in this directory is not an endorsement.